Home


Login | Forgot password?
February 9, 2010
A new path to hope

Brainsgate is a medical device company committed to developing a novel treatment modality, electrical SPG stimulation. This platform technology has been shown to increase blood flow to the brain and as a result has broad potential for treating central nervous system disorders. BrainsGate is currently focusing on:

1. Improve the outcome of patients suffering from ischemic stroke, in a 24 hour window after onset of symptoms.

2. Long-term SPG stimulation for the treatment of vascular dementia patients.


Focus: the spheno-palatine ganglion
Two small nervous centers located above the roof of the mouth near the sinuses read more
Focus: Stroke
The leading cause of adult long-term disability and the third leading cause of death read more
November 17, 2009
Investigational neurostimulation device aims to reduce stroke damage
Stroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24 (PhysOrg.com) > full story
May 26, 2009
ESC 2009
BrainsGate attends the ESC 2009 in Stockholm > full story